Mark Crossley
Former Chief Executive Officer (until May 8, 2025)
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Indivior Pharmaceuticals, Inc. (INDV) | — | $902,261 | $3,185,591 |
Executive changes
Earnings-call appearances
-
Indivior Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-04-24
Indivior Pharmaceuticals, Inc. (INDV)